Danniel A. Zamora

Infectious Disease

1000 Fivepoint Ste A
Irvine, CA 92618

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Genetic and environmental imprints on T cell receptor repertoires as predictors of graft-versus-host disease.

Genetic and environmental imprints on T cell receptor repertoires as predictors of graft-versus-host disease.

Journal: bioRxiv : the preprint server for biology

Published: January 07, 2026

New Insights Into Factors Shaping CMV-Specific T-Cell Polyfunctionality After Hematopoietic Cell Transplantation.

New Insights Into Factors Shaping CMV-Specific T-Cell Polyfunctionality After Hematopoietic Cell Transplantation.

Journal: American journal of hematology

Published: September 28, 2025

Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes.

Cytomegalovirus DNAemia in Hospitalized Adults With SARS-CoV-2 Infection Requiring Supplemental Oxygen: Virologic and Clinical Characteristics and Association With Outcomes.

Journal: The Journal of infectious diseases

Published: September 24, 2025

Mortality Associated With Cytomegalovirus Reactivation After Umbilical Cord Blood HCT.

Mortality Associated With Cytomegalovirus Reactivation After Umbilical Cord Blood HCT.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: August 19, 2025

Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation Success.

Cytomegalovirus Viral Load Continues to Predict Poor Outcomes in Adults and Children Despite Improved Hematopoietic Cell Transplantation Success.

Journal: Open forum infectious diseases

Published: July 07, 2025

American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients.

American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients.

Journal: Transplantation and cellular therapy

Published: June 19, 2025

ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.

ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipients.

Journal: Bone marrow transplantation

Published: February 04, 2025

Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.

Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis.

Journal: JCI insight

Published: February 16, 2024

CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.

CMV reactivation during pretransplantation evaluation: a novel risk factor for posttransplantation CMV reactivation.

Journal: Blood advances

Published: November 20, 2023

Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques.

Late cytomegalovirus disease after hematopoietic cell transplantation: significance of novel transplantation techniques.

Journal: Blood advances

Published: November 13, 2023

Like watching a soccer game through a keyhole: Cytomegalovirus cell-mediated immunity incompletely reveals risk for clinically significant cytomegalovirus reactivation in cord blood transplant recipients.

Like watching a soccer game through a keyhole: Cytomegalovirus cell-mediated immunity incompletely reveals risk for clinically significant cytomegalovirus reactivation in cord blood transplant recipients.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: July 26, 2023

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Human herpesvirus-6 reactivation and disease after allogeneic haematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: April 04, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026